José Ignacio
López Villalba
Publicaciones en las que colabora con José Ignacio López Villalba (88)
2024
-
Distinct spatial landscapes in clear-cell renal cell carcinoma as revealed by whole transcriptome analysis
Immuno-Oncology and Technology, Vol. 21
-
The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy
International Journal of Molecular Sciences, Vol. 25, Núm. 3
2022
-
Clear Cell Renal Cell Carcinomas with Aggressive Behavior Display Low Intratumor Heterogeneity at the Histological Level
Current Urology Reports, Vol. 23, Núm. 6, pp. 93-97
-
Urological Cancer Panorama in the Second Year of the COVID-19 Pandemic
Cancers
2021
-
(Pro)renin receptor is a novel independent prognostic marker in invasive urothelial carcinoma of the bladder
Cancers, Vol. 13, Núm. 22
-
Clinical implications of (Pro)renin receptor (prr) expression in renal tumours
Diagnostics, Vol. 11, Núm. 2
-
Mimickers of urothelial carcinoma and the approach to differential diagnosis
Clinics and Practice, Vol. 11, Núm. 1, pp. 110-123
-
Soluble pd-l1 is an independent prognostic factor in clear cell renal cell carcinoma
Cancers, Vol. 13, Núm. 4, pp. 1-17
-
The role of epigenetics in the progression of clear cell renal cell carcinoma and the basis for future epigenetic treatments
Cancers, Vol. 13, Núm. 9
2020
-
Altered tissue and plasma levels of fibroblast activation protein-α (FAP) in renal tumours
Cancers, Vol. 12, Núm. 11, pp. 1-16
2019
-
A Critical Insight into the Clinical Translation of PD-1/PD-L1 Blockade Therapy in Clear Cell Renal Cell Carcinoma
Current Urology Reports, Vol. 20, Núm. 1
-
Common and uncommon features of nephrogenic adenoma revisited
Pathology Research and Practice, Vol. 215, Núm. 10
-
Precise definition of PTEN C-terminal epitopes and its implications in clinical oncology
npj Precision Oncology, Vol. 3, Núm. 1
-
Precise immunodetection of PTEN protein in human neoplasia
Cold Spring Harbor Perspectives in Medicine, Vol. 9, Núm. 12
-
The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder
Human Pathology, Vol. 91, pp. 61-68
2018
-
High levels of intratumor heterogeneity characterize the expression of epithelial-mesenchymal transition markers in high-grade clear cell renal cell carcinoma
Annals of Diagnostic Pathology, Vol. 34, pp. 27-30
-
Loss of PD-L1 (SP-142) expression characterizes renal vein tumor thrombus microenvironment in clear cell renal cell carcinoma
Annals of Diagnostic Pathology, Vol. 34, pp. 89-93
-
Pathological Bases and Clinical Impact of Intratumor Heterogeneity in Clear Cell Renal Cell Carcinoma
Current Urology Reports, Vol. 19, Núm. 1
-
Potential impact of PD-L1 (SP-142) immunohistochemical heterogeneity in clear cell renal cell carcinoma immunotherapy
Pathology Research and Practice, Vol. 214, Núm. 8, pp. 1110-1114